Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.

[1]  D. Nomura,et al.  Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products. , 2017, Cell chemical biology.

[2]  C. Skibola,et al.  Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity. , 2017, Chemical communications.

[3]  D. Nomura,et al.  Mapping Novel Metabolic Nodes Targeted by Anti-Cancer Drugs that Impair Triple-Negative Breast Cancer Pathogenicity. , 2017, ACS chemical biology.

[4]  C. Skibola,et al.  Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. , 2017, ACS chemical biology.

[5]  D. Nomura,et al.  Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots. , 2017, Current opinion in biotechnology.

[6]  J. Balko,et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease , 2016, Nature Reviews Clinical Oncology.

[7]  B. Cravatt,et al.  Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells , 2016, Science Signaling.

[8]  B. Dhananjaya,et al.  Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study , 2016, Pharmaceutical biology.

[9]  Umut Ozcan,et al.  Withaferin A is a Leptin Sensitizer with Strong Anti-Diabetic Properties in Mice , 2016, Nature Medicine.

[10]  M. Lahtela-Kakkonen,et al.  Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway. , 2016, Biochemical pharmacology.

[11]  D. Nomura,et al.  GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity. , 2016, Cell chemical biology.

[12]  A. Olson,et al.  Proteome-wide covalent ligand discovery in native biological systems , 2016, Nature.

[13]  M. Galsky,et al.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase , 2016, The FEBS journal.

[14]  In-Chul Lee,et al.  Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action , 2016, International journal of molecular sciences.

[15]  D. Nomura,et al.  Mapping proteome-wide interactions of reactive chemicals using chemoproteomic platforms. , 2016, Current opinion in chemical biology.

[16]  Youli Xiao,et al.  Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics. , 2016, Molecular bioSystems.

[17]  John D. Venable,et al.  ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity. , 2015, Journal of proteomics.

[18]  K. Fisher,et al.  Mapping Proteome-Wide Targets of Environmental Chemicals Using Reactivity-Based Chemoproteomic Platforms. , 2015, Chemistry & biology.

[19]  A. Adibekian,et al.  Proteome-Wide Profiling of Targets of Cysteine reactive Small Molecules by Using Ethynyl Benziodoxolone Reagents. , 2015, Angewandte Chemie.

[20]  A. Hamid,et al.  Pharmacologic overview of Withania somnifera, the Indian Ginseng , 2015, Cellular and Molecular Life Sciences.

[21]  Donna D. Zhang,et al.  Withaferin A Analogs That Target the AAA+ Chaperone p97. , 2015, ACS chemical biology.

[22]  M. Lahtela-Kakkonen,et al.  Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ. , 2014, Biochemical pharmacology.

[23]  Melinda M. Mulvihill,et al.  Inositol Phosphate Recycling Regulates Glycolytic and Lipid Metabolism That Drives Cancer Aggressiveness , 2014, ACS chemical biology.

[24]  Benjamin F. Cravatt,et al.  A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles , 2013, Nature Methods.

[25]  Melinda M. Mulvihill,et al.  Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity , 2013, Proceedings of the National Academy of Sciences.

[26]  David Baker,et al.  Quantitative reactivity profiling predicts functional cysteines in proteomes , 2010, Nature.

[27]  Tao Zhang,et al.  Withaferin A targets heat shock protein 90 in pancreatic cancer cells. , 2010, Biochemical pharmacology.

[28]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[29]  Chang-Guo Zhan,et al.  The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. , 2007, Chemistry & biology.

[30]  Wenqing Xu,et al.  Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme , 2007, Nature.

[31]  B. Cravatt,et al.  Protein-reactive natural products. , 2005, Angewandte Chemie.

[32]  Nasreen S Jessani,et al.  Breast Cancer Cell Lines Grown In Vivo: What Goes in Isn’t Always the Same as What Comes Out , 2005, Cell cycle.

[33]  John R Yates,et al.  Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.